543 related articles for article (PubMed ID: 12943738)
1. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
Bhavnani BR
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
Bhavnani BR
Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action.
Bhavnani BR; Stanczyk FZ
J Steroid Biochem Mol Biol; 2014 Jul; 142():16-29. PubMed ID: 24176763
[TBL] [Abstract][Full Text] [Related]
6. Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death.
Berco M; Bhavnani BR
J Soc Gynecol Investig; 2001; 8(4):245-54. PubMed ID: 11525901
[TBL] [Abstract][Full Text] [Related]
7. Equine estrogens differentially prevent neuronal cell death induced by glutamate.
Bhavnani BR; Berco M; Binkley J
J Soc Gynecol Investig; 2003 Jul; 10(5):302-8. PubMed ID: 12853093
[TBL] [Abstract][Full Text] [Related]
8. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
9. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR; Tam SP; Lu X
Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of 17 beta-dihydroequilin sulfate in normal postmenopausal women under steady state conditions.
Bhavnani BR; Cecutti A; Gerulath A
J Soc Gynecol Investig; 2002; 9(2):102-10. PubMed ID: 12398033
[TBL] [Abstract][Full Text] [Related]
11. Metabolic clearance rate of equilin sulfate and its conversion to plasma equilin, conjugated and unconjugated equilenin, 17 beta-dihydroequilin, and 17 beta-dihydroequilenin in normal postmenopausal women and men under steady state conditions.
Bhavnani BR; Cecutti A
J Clin Endocrinol Metab; 1993 Nov; 77(5):1269-74. PubMed ID: 8077320
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in silico analyses of estrogenic potential of equine estrogens in medaka (Oryzias latipes).
Ishibashi H; Uchida M; Hirano M; Hayashi T; Yamamoto R; Kubota A; Ichikawa N; Ishibashi Y; Tominaga N; Arizono K
Sci Total Environ; 2021 May; 767():144379. PubMed ID: 33421642
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women.
Bhavnani BR; Nisker JA; Martin J; Aletebi F; Watson L; Milne JK
J Soc Gynecol Investig; 2000; 7(3):175-83. PubMed ID: 10865186
[TBL] [Abstract][Full Text] [Related]
14. Interaction of ring B unsaturated estrogens with estrogen receptors of human endometrium and rat uterus.
Bhavnani BR; Woolever CA
Steroids; 1991 Apr; 56(4):201-10. PubMed ID: 1871786
[TBL] [Abstract][Full Text] [Related]
15. Endocrine-disrupting potentials of equine estrogens equilin, equilenin, and their metabolites, in the medaka Oryzias latipes: in silico and DNA microarray studies.
Uchida M; Ishibashi H; Yamamoto R; Koyanagi A; Kusano T; Tominaga N; Ishibashi Y; Arizono K
J Appl Toxicol; 2015 Sep; 35(9):1040-8. PubMed ID: 25611945
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men.
Bhavnani BR; Cecutti A; Gerulath A
J Steroid Biochem Mol Biol; 1998 Oct; 67(2):119-31. PubMed ID: 9877212
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 17 beta-dihydroequilin sulfate and 17 beta-dihydroequilin in normal postmenopausal women.
Bhavnani BR; Cecutti A
J Clin Endocrinol Metab; 1994 Jan; 78(1):197-204. PubMed ID: 8288704
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analyses of vitellogenin, choriogenin and estrogen receptor subtypes in the livers of male medaka (Oryzias latipes) exposed to equine estrogens.
Ishibashi H; Uchida M; Koyanagi A; Kagami Y; Kusano T; Nakao A; Yamamoto R; Ichikawa N; Tominaga N; Ishibashi Y; Arizono K
J Appl Toxicol; 2016 Nov; 36(11):1392-400. PubMed ID: 26863931
[TBL] [Abstract][Full Text] [Related]
19. Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death.
Zhang Y; Lu X; Bhavnani BR
BMC Neurosci; 2003 Dec; 4():32. PubMed ID: 14693041
[TBL] [Abstract][Full Text] [Related]
20. Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women.
Perrella J; Berco M; Cecutti A; Gerulath A; Bhavnani BR
Lipids Health Dis; 2003 Jun; 2():4. PubMed ID: 12848896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
